Goldman Sachs BDC (GSBD) Q2 2026 earnings review
Headline Earnings Beat Masks Low-Quality Income and Stalled Originations
GSBD printed an optically strong Net Investment Income (NII) of $0.38 per share, rebounding from Q1's dismal $0.22 and fully covering its $0.32 base dividend. However, this 'beat' is a mirage: it was driven entirely by a $5M one-time catch-up payment and a $0 incentive fee accrual (thanks to a 3-year lookback mechanism). Beneath the surface, core portfolio momentum is decelerating rapidly. Originations ground to a near-halt at just $12.9M, vastly outpaced by $145.9M in repayments. Furthermore, legacy portfolio markdowns caused Net Asset Value (NAV) to bleed another 0.9% to $12.06. The silver lining? The massive repayment wave successfully pulled leverage down to 1.35x (and below the 1.25x target post-quarter), finally unlocking the capacity to deploy the $75M share repurchase program.
🐂 Bull Case
The Q2 repayment wave forced leverage down. Post-quarter, net debt-to-equity sits below the 1.25x target, allowing management to immediately pivot to deploying the newly authorized $75M stock repurchase program at accretive prices.
Though Q2 volume was abysmal, pricing power is improving. Management noted weighted average spreads on Q2 originations hit 511 basis points (wider than 6 months ago) with highly conservative loan-to-values of 37.4%.
🐻 Bear Case
Excluding the $5M one-time catch-up and assuming a normalized incentive fee, core run-rate NII does not cover the $0.32 dividend. The company is currently relying on mechanical fee holidays and legacy spillover income.
NAV dropped again to $12.06. While non-accruals at Fair Value dipped to 2.9%, non-accruals at Amortized Cost actually rose to 5.0%, indicating management is taking severe write-downs to clear out bad pre-2022 vintage loans.
⚖️ Verdict: 🔴
Bearish. The headline earnings beat relies on accounting mechanics rather than fundamental portfolio strength. Stalled originations and an ongoing bleed in the legacy portfolio outweigh the benefits of improved leverage.
Key Themes
Low-Quality NII Rebound
Net Investment Income rebounded sharply to $0.38, but the quality of this income is exceptionally poor. The beat was entirely propped up by two non-recurring factors: a complete lack of incentive fees (which were $12.4M earlier in the year but zeroed out due to a 3-year total return lookback) and roughly $5M in one-time catch-up income from a legacy loan (Thrasio) returning to accrual status, plus accelerated OID. Without these anomalies, core run-rate income is decelerating and falls short of the $0.32 dividend threshold.
Leverage Reset Activates Repurchase Engine
Net debt-to-equity peaked at 1.37x in Q1, paralyzing capital deployment. The massive Q2 repayment wave ($145.9M) pulled leverage down to 1.35x by quarter-end, and post-quarter activity dragged it comfortably below the 1.25x target. This dynamic reverses the previous capital constraint, immediately freeing GSBD to act on its new $75M 10b5-1 share repurchase program—a highly accretive lever while the stock trades below NAV.
Non-Accrual Costs Continue to Rise Despite Markdowns
Management touted a drop in non-accruals at Fair Value (to 2.9% from 3.2%). However, looking at Amortized Cost reveals a deteriorating picture: non-accruals accelerated to 5.0%, up from 4.7% in Q1 and 2.8% in Q4. Two investments in Wine.com were placed on non-accrual this quarter. The divergence between Fair Value and Cost means GSBD is taking heavy unrealized losses to write down these distressed assets, which directly caused the NAV erosion to $12.06.
AI Framework Validating Software Underwriting
Addressing widespread market fears about AI rendering legacy SaaS models obsolete, management highlighted that their proprietary AI underwriting framework is working. The framework actively avoids vulnerable platforms in favor of 'verticalized, incumbent software providers with proprietary data.' According to management, this specific cohort is currently outperforming the broader portfolio, offering a defense against terminal-value collapse in software lending.
Subdued Macro M&A and Leadership Shuffle
Originations completely stalled in Q2, with a paltry $12.9M in new commitments. Management blamed a 38% sequential drop in private equity deal volumes and a 33% drop in sponsored loan issuance. Compounding the transition period, Co-CEO David Miller announced he will step down at year-end, handing full control to Vivek Bantwal. While management claims M&A picked up rapidly in July/August, the Q2 stall leaves the portfolio entirely reliant on future macro recovery.
Other KPIs
Decelerating. NAV declined by 0.9% quarter-over-quarter, compounding the 3.7% drop witnessed in Q1. The erosion was primarily driven by $18.6M in net realized and unrealized losses stemming from the legacy pre-2022 portfolio.
Reversing. After climbing steadily for three quarters and peaking at 1.37x in Q1, leverage has finally tipped downward. Elevated Q2 repayments and post-quarter BSL refinancing activity have pushed pro-forma leverage back below the firm's 1.25x target, restoring operational flexibility.
Reversing. TII rebounded from $78.8M in Q1. However, this was largely an accounting reversal, driven by restoring a major legacy non-accrual (Thrasio) to accrual status and accelerating Original Issue Discount (OID) recognition, rather than organic portfolio growth.
Guidance
Stable. Maintained at the current level. Management notes the dividend remains supported by $100.3M ($0.89 per share) of undistributed taxable spillover income, providing a substantial cushion while core run-rate earnings recover.
Stable. Paid out in accordance with the firm's framework of distributing excess NII, though heavily reliant on this quarter's lack of incentive fees to justify the math.
Accelerating. With leverage now reportedly below 1.25x post-quarter, management explicitly signaled the intention to 'reactivate' stock repurchases under this 10b5-1 plan, rotating repayment capital directly into discounted GSBD shares.
Key Questions
Normalized NII Runway
Given the $5M one-time catch-up and the zero incentive fee this quarter, what is the core run-rate NII assuming standard fee accruals, and how long will the 3-year lookback mechanism suppress incentive fees?
Legacy Book Pain Point
Non-accruals at amortized cost increased to 5.0% despite heavy markdowns. What is the total remaining exposure to the pre-2022 legacy book, and how much further NAV erosion should investors model before this book is fully cycled out?
Capital Allocation Priority
With pro-forma leverage back below 1.25x and M&A reportedly picking up post-quarter, will you prioritize defending NAV via the $75M buyback, or capturing wider spreads via new originations?